Table 3.

GI complications and mortality in ELAB patients (%)

Stage	n	AE	SU	SSU	FA	EI	Mortality
1	45	24.4	60.0	11.1	20.0	15.5	55.6
2	29	13.8	48.3	6.9	13.8	10.3	41.3
3	56	7.1a	21.4bc	3.6	8.9	7.1	28.5b

Compared with stage 1,

^aP < 0.05,

^bP < 0.01; compared with stage 2,

^cP < 0.05.